EFFECTS OF ARACHIDONIC ACID AND BRADYKININ ON THE CORONARY FLOW, RELEASE OF PGI<SUP>2</SUP> AND CARDIAC FUNCTIONS IN THE PERFUSED GUINEA-PIG HEART
スポンサーリンク
概要
- 論文の詳細を見る
The contribution of prostacyclin (PGI<SUB>2</SUB>) to the coronary vasodilating action of arachidonic acid (AA) and bradykinin (BK) was examined in isolated perfused guinea-pig hearts. The injection of AA (100 to 1, 000 ng) and BK (1 to 100 ng) into the heart resulted in a dose-dependent increase in the total amount of coronary flow and a release of 6-keto-prostaglandin F<SUB>1α</SUB>, a stable metabolite of PGI<SUB>2</SUB>. Both AA and BK showed weak positive chronotropic effects. In addition, higher doses (300 and 1, 000 ng) of AA caused a transient reduction in the coronary flow rate, left ventricular systolic pressure, and left ventricular dp/dt. The changes in coronary flow, release of PGI<SUB>2</SUB>, and all cardiodynamic parameters induced by AA were abolished by pretreatment of the preparation with diclofenac-Na. On the other hand, the BK-induced increase in coronary flow rate was only partially reduced by diclofenac-Na when the release of 6-keto-prostaglandin F<SUB>1α</SUB> was completely inhibited. It is concluded that in isolated perfused guinea-pig hearts, BK has both PGI<SUB>2</SUB>-independent and PGI<SUB>2</SUB>-dependent coronary vasodilating actions; the latter action is less than 25%, and the coronary vasodilating action of AA is mainly mediated <I>via</I> PGI<SUB>2</SUB>.
- 社団法人 日本薬理学会の論文
著者
-
TERASHITA ZEN-ICHI
Central Research Division, Takeda Chemical Industry, Ltd.
-
NISHIKAWA KOHEI
Central Research Division, Takeda Chemical Industry, Ltd.
-
Terashita Z
New Generation Research Laboratory Takeda Chemical Industries Ltd.
-
Hirata Minoru
Central Research Division Takeda Chemical Industry Ltd.
-
FUKUI Hiroshi
Central Research Division, Takeda Chemical Industries, Ltd.
-
KIKUCHI Shintaro
Central Research Division, Takeda Chemical Industries, Ltd.
-
HIRATA Minoru
Central Research Division, Takeda Chemical Industries, Ltd.
-
NISHIKAWA Kohei
Central Research Division, Takeda Chemical Industries, Ltd.
-
TERASHITA Zen-ichi
Central Research Division, Takeda Chemical Industries, Ltd.
関連論文
- Orally Active GPIIb/IIIa Antagonists : Synthesis and Biological Activities of Masked Amidines as Prodrugs of 2-[(3S)-4-[(2S)-2-(4-Amidinobenzoylamino)-3-(4-methoxyphenyl)propanoyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl]acetic Acid
- Novel Non-Peptide GPIIb/IIIa Antagonists : Synthesis and Biological Activities of 2-[4-[2-(4-Amidinobenzoylamino)-2-(substituted)acetyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl]acetic Acids
- THROMBOXANE SYNTHETASE INHIBITORS (TXSI). SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF CV-4151
- 2-O-ALKYLASCORBIC ACID DERIVATIVES WITH SCAVENGING ACTIVITY AGAINST ACTIVE OXYGEN SPECIES (AOS)
- Inhibition of Angiotensin Converting Enzyme by CV-3317 a Non-Sulfhydryl Compound
- EFFECTS OF ARACHIDONIC ACID AND BRADYKININ ON THE CORONARY FLOW, RELEASE OF PGI2 AND CARDIAC FUNCTIONS IN THE PERFUSED GUINEA-PIG HEART
- Antihypertensive action of a non-sulfhydryl angiotensin converting enzyme inhibitor (CV-3317) in various hypertensive models.